Correction

Correction

It was not Alkermes who made Exubera but a company called Nektar which was previously known as Inhaled Therapeutics that made Exubera. Alkermes did have an inhaled insulin partnership with Lilly (NYSE:LLY) but that never came to market. It’s also worth noting that Novo Nordisk also had an inhaled insulin that failed.

Truly sorry about the confusion but there have been so many of these damn things it’s hard to keep them all straight.